Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure

BACKGROUND: This study aimed to determine the maximum tolerated dose (MTD), dose-limiting toxicity, and efficacy of second-line chemotherapy with FOLFIRINOX after gemcitabine (GEM)-based chemotherapy failure in metastatic pancreatic cancer (MPC). METHODS: We studied 18 histopathologically proven MPC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Kobayashi, Noritoshi, Shimamura, Takeshi, Tokuhisa, Motohiko, Goto, Ayumu, Endo, Itaru, Ichikawa, Yasushi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2017
Soggetti:
4500
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5428587/
https://ncbi.nlm.nih.gov/pubmed/28489753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006769
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi